Update on the evaluation and management of functional dyspepsia

American Family Physician

Volumn 83, Issue 5, 2011, Pages 547-552

  Loyd, Ryan A ^a   McClellan, David A ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; AMITRIPTYLINE; ANTACID AGENT; ANTIDEPRESSANT AGENT; BISMUTH SALT; BISPHOSPHONIC ACID DERIVATIVE; CISAPRIDE; CYCLOOXYGENASE 2 INHIBITOR; DOMPERIDONE; ERYTHROMYCIN; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; METFORMIN; METOCLOPRAMIDE; MIGLITOL; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; PREDNISONE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; SUCRALFATE; TETRAHYDROLIPSTATIN; THEOPHYLLINE;

ANXIETY DISORDER; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HELICOBACTER INFECTION; HUMAN; INTESTINE ULCER; IRRITABLE COLON; LOW DRUG DOSE; PARKINSONISM; PSYCHIATRIC TREATMENT; STOMACH PARESIS; TARDIVE DYSKINESIA; TREATMENT PLANNING; DRUG EFFECT; GASTROINTESTINAL MOTILITY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SECRETION; STOMACH ACID;

ANTIDEPRESSIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; GASTRIC ACID; GASTROINTESTINAL MOTILITY; HUMANS;

EID: 79955973962     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. McNamara DA, Buckley M, O'Morain CA. Nonulcer dyspepsia. Current concepts and management. Gastroenterol Clin North Am. 2000;29(4):807-818.
2. McQuaid K. Dyspepsia. In: Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysi-ology, Diagnosis, Management. 7th ed. Philadelphia, Pa.: Saunders; 2002:102-103.
3. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders [published correction appears in Gastroenterology. 2006;131(1):336]. Gastroenterology. 2006;130(5):1466-1479.
4. Drossman DA, Corazziari E, Delvaux M, et al. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, Va.: Degnon Associates; 2006. http://theromefoundation.org/assets/pdf/19_RomeIII_apA_885-898.pdf. Accessed June 15, 2010.
5. Talley NJ. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129(5): 1753-1755.
6. Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastro-enterol Hepatol. 2010;25(6):1151-1156.
7. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008;28(8):1013-1020.
8. Sha W, Pasricha PJ, Chen JD. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol. 2009;43(8):716-722.
9. Sha W, Pasricha PJ, Chen JD. Rhythmic and spatial abnormalities of gastric slow waves in patients with functional dyspepsia. J Clin Gastroen-terol. 2009;43(2):123-129.
10. Mizushima T, Sawa K, Ochi K, et al. Gastrobiliary motility is not coordinated in patients with non-ulcer dyspepsia of normal gastric emptying time: simultaneous sonographic study. J Gastroenterol Hepatol. 2005;20(6):910-914.
11. Lin X, Levanon D, Chen JD. Impaired postprandial gastric slow waves in patients with functional dyspepsia. Dig Dis Sci. 1998;43(8):1678-1684.
12. Lin Z, Eaker EY, Sarosiek I, McCallum RW. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gas-troenterol. 1999;94(9):2384-2389.
13. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol. 2009;43(6):527-533.
14. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gas-troenterol Suppl. 1996;215:38-47.
15. Value of the unaided clinical diagnosis in dyspeptic patients in primary care. Am J Gastroenterol. 2001;96(5):1417-1421.
16. Bazaldua OV, Schneider FD. Evaluation and management of dyspepsia. Am Fam Physician. 1999;60(6):1773-1784.
17. Talley NJ, Silverstein MD, Agréus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998;114(3):582-595.
18. Fisher RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med. 1998;339(19):1376-1381.
19. Dickerson LM, King DE. Evaluation and management of nonulcer dyspepsia. Am Fam Physician. 2004;70(1):107-114.
20. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006; 295(13):1566-1576.
21. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2005;(4): CD001961.
22. Ables AZ, Simon I, Melton ER. Update on Helicobacter pylori treatment. Am Fam Physician. 2007;75(3):351-358.
23. Marmo R, Rotondano G, Piscopo R, et al. Combination of age and sex improves the ability to predict upper gastrointestinal malignancy in patients with uncomplicated dyspepsia: a prospective multicentre database study. Am J Gastroenterol. 2005;100(4):784-791.
24. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;(4): CD001960.
25. Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician. 2007;75(7): 1027-1030.
26. Melzer J, Rösch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phyto-therapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther. 2004;20(11-12):1279-1287.
27. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;(2): CD002096.
28. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108(1):65-72.
29. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol. 1998;93(2):160-165.
30. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137(4):1261-1269.
31. Talley NJ, Herrick L, Locke GR. Antidepressants in functional dyspepsia. Expert Rev Gastroenterol Hepatol. 2010;4(1):5-8.
32. Soo S, Moayyedi P, Deeks J, Delaney B, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005;(2): CD002301.